Research Peptides
5 pharmaceutical-grade compounds available
Nexora Pharma Ipamorelin 5mg
Nexora Pharma Ipamorelin 5mg is a synthetic pentapeptide belonging to the growth hormone secretagogue class. Researched extensively for its role in selectively stimulating growth hormone release via ghrelin receptor activation, with a more targeted receptor profile compared to earlier-generation secretagogues. This peptide demonstrates notable activity in preclinical models examining GH pulsatility, minimal cortisol/prolactin co-release, and metabolic/recovery research applications. Lab verified 99%+ purity.
Nexora Pharma CJC-1295 (Without DAC) 5mg
Nexora Pharma CJC-1295 (Without DAC) 5mg is a synthetic analog of growth hormone-releasing hormone (GHRH), also known as Mod GRF 1-29. Researched extensively for its role in stimulating endogenous growth hormone secretion through GHRH receptor activation, without the extended half-life modification of the DAC variant. This peptide demonstrates notable activity in preclinical models examining pulsatile GH release, IGF-1 production, and metabolic/recovery research applications. Lab verified 99%+ purity.
Nexora Pharma GHRP-6 + CJC (Without DAC) 5mg/5mg
Nexora Pharma GHRP-6 + CJC-1295 (Without DAC) 5mg/5mg is a synthetic peptide blend combining GHRP-6, a growth hormone secretagogue that stimulates GH release via ghrelin receptor activation, with CJC-1295 (Without DAC), a modified growth hormone-releasing hormone (GHRH) analog. Researched extensively for its combined effects on GH pulsatility, synergistic secretagogue signaling, and metabolic/recovery pathways. This stacked formulation is studied in preclinical models examining amplified GH release compared to either peptide alone, along with downstream effects on IGF-1 production and tissue recovery research applications. Lab verified 99%+ purity.
Nexora Pharma GHRP-6 5mg
Nexora Pharma GHRP-6 5mg is a synthetic hexapeptide belonging to the growth hormone secretagogue class. Researched extensively for its role in stimulating growth hormone release via ghrelin receptor activation, along with studied effects on appetite regulation and cellular recovery pathways. This stable peptide demonstrates notable activity in preclinical models examining GH pulsatility, tissue repair support, and metabolic research applications. Lab verified 99%+ purity.
Nexora Pharma MOTS-c 10mg
Nexora Pharma MOTS-c 10mg is a synthetic mitochondrial-derived peptide (MDP) encoded within the mitochondrial genome. Researched extensively for its role in metabolic regulation, insulin sensitivity, and exercise-mimetic cellular pathways. This stable peptide demonstrates notable activity in preclinical models examining AMPK activation, mitochondrial homeostasis, and metabolic stress response. Lab verified 99%+ purity.